Multigene testing should be offered to all women with breast cancer, rather than be offered on the basis of family history or clinical characteristics, a new study suggests. Testing of all unselected patients with breast cancer for BRCA1/BRCA2/PALB2 would identify many more gene carriers and potentially prevent many cases of breast cancer and ovarian cancer, according ...
Unselected multigene testing supported for all patients with breast cancer
By Michael Woodhead
22 Oct 2019